In contrast, reductions in GAG in mice treated at the low dose of 1E12 vg/kg did not reach statistical significance in any tissue compared to untreated animals.
← all excerpts
Functional correction of neurological and somatic disorders at later stages of disease in MPS IIIA mice by systemic scAAV9-hSGSH gene delivery.
1
—
—